Pacira BioSciences, Inc. (Nasdaq: PCRX), the industry leader in the delivery of innovative, non-opioid pain therapies, today ...

Scilex Holding Company (Nasdaq: SCLX, “Scilex” or “Company”), an innovative revenue-generating company focused on acquiring, developing and commercializing non-opioid pain management products for the ...

Thriving United provides free Narcan kits and training in Midland to help combat opioid overdoses, including those from ...

Screening people at risk for opioid use disorder when they’re admitted to the hospital could keep them from being readmitted, ...

World trade on the brink of crisis. Trump's tariff policy has caused stock exchanges to crash and is putting pressure on ...

The Trump administration is putting its weight behind an effort to stop drug manufacturers from changing how a safety-net ...

The CDC marked a major uptick in group A strep cases in 10 U.S. states from 2013 to 2022. Here's what to know about risk of ...

Dogwood Therapeutics, Inc. (Nasdaq: DWTX) (the “Company”), a development-stage biopharmaceutical company focused on ...

It’s been called “Ozempic for alcohol,” for its ability to reduce cravings, yet most people struggling with addiction have ...

In a best practice guideline, advice is presented for clinicians regarding the benefits and harms of cannabis or cannabinoids for the management of chronic noncancer pain.

Numerous treatment options for COVID-19 have been approved by the U.S. Food and Drug Administration over the last four years, ...

The global chronic ocular pain market, valued at US$ 7.19 billion in 2023, is poised for substantial growth, with a projected market valuation of US$ 12.44 billion by 2032. This growth is driven by an ...